Symbol
| SLC27A1
| contributors: mct/pgu - updated : 11-01-2017
|
HGNC name
| solute carrier family 27 (fatty acid transporter), member 1
|
HGNC id
| 10995
|
corresponding disease(s)
|
MROS2
|
Other morbid association(s)
|
Type | Gene Modification | Chromosome rearrangement | Protein expression | Protein Function
|
---|
constitutional
|  
|  
| --over
|  
|
in skeletal muscle increased the rate of SLC27A1 transport and channelled these lipids to oxidation, not to intramuscular lipid accumulation | constitutional
|  
|  
| --over
|  
|
upon weight loss in morbidly obese patients | |
Variant & Polymorphism
SNP
| associated with increased plasma triglycerides and alteration in LDL particle distribution |
|
|
Candidate gene
Marker
Therapy target
|
System | Type | Disorder | Pubmed |
diabete | | | |
antidiabetic target |
| | | |
| skeletal muscle Slc27a1 overabundance does not predispose animals to diet-induced insulin resistance |